Stocks in news:

• Board meetings:
  JB Chemicals to consider buy back
  Prism Cement, Vakrangee Software results
  Vyapar Industries on issue of convertible warrants
• Global update: Alcoa net profit falls 45% on higher input costs, falling dollar; Nalco, Hindlaco in focus
• Bharat Forge buys Sifcor of France - ET 
• RIL strikes oil in Yemen - ET
• IOL Chem in talks with PE players to sell 5% stake, plans to mope Rs 80 cr - DNA
• Natco Pharma planning another patent fight against Pfizer's new anti-HIV drug Celzentry - Mint
• Indian ADRs:
  ICICI Bank up 6.8%, HDFC Bank up 6%, Sterlite up 5%
• S Kumars
  Ex-date for demerger of retail biz on Apr 24
  All existing F&O contracts will expire on Apr 23
• NMDC has sought hike in iron ore prices by 60% - FE
• Vishal Retail to step into cash & carry segment, plans Rs 700 cr expansion- DNA
• Few takers for exotic forex derivatives now - BL
• 3 groups infra fund exceeds $1bn target, PE show faith in India growth
• Auto cos may hike prices as they feel the heat of costlier steel prices
• CACP – Commission For Agricultural Costs & Prices which fixes SMP, says
  Difference between SMP & SAP has to be borne by the govet and not sugar mills: Sources
• Solrex Pharma Hikes Stake In Orchid~Chem To 11.39% From 8.06%
  CNBC-TV18 Reported Solrex Picking~Up Stake In Orchid Chem Yesterday
  Orchid Chem Was Up 16% Yesterday~On CNBC-TV18 Report
  Solrex Pharma Is A Partnership Firm~Floated By Ranbaxy Promoters: Srcs